Group One Trading
FOLD

Group One Trading’s Amicus Therapeutics FOLD Stock Holding History

Group One Trading’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$353K Sell
24,400
-17,100
-41% -$245K ﹤0.01% 3658
2025
Q4 		$591K Sell
41,500
-1,400
-3% -$13.8K ﹤0.01% 3338
2025
Q3 		$338K Buy
42,900
+32,400
+309% +$231K ﹤0.01% 4107
2025
Q2 		$60.2K Sell
10,500
-5,700
-35% -$36.8K ﹤0.01% 5428
2025
Q1 		$132K Buy
16,200
+15,600
+2,600% +$144K ﹤0.01% 4381
2024
Q4 		$5.65K Buy
600
+400
+200% +$4.16K ﹤0.01% 6369
2024
Q3 		$2.14K Sell
200
-200
-50% -$2.18K ﹤0.01% 6126
2024
Q2 		$3.97K Buy
+400
New +$4.11K ﹤0.01% 6044
2024
Q1 		– Sell
-30,600
Closed -$434K – 7322
2023
Q4 		$434K Sell
30,600
-26,700
-47% -$303K ﹤0.01% 3185
2023
Q3 		$697K Buy
57,300
+45,100
+370% +$582K ﹤0.01% 2600
2023
Q2 		$153K Buy
12,200
+11,900
+3,967% +$141K ﹤0.01% 4207
2023
Q1 		$3.33K Sell
300
-3,800
-93% -$46.8K ﹤0.01% 6461
2022
Q4 		$50.1K Sell
4,100
-3,600
-47% -$40.5K ﹤0.01% 4989
2022
Q3 		$80K Sell
7,700
-5,700
-43% -$63.5K ﹤0.01% 4986
2022
Q2 		$144K Buy
13,400
+8,800
+191% +$72.5K ﹤0.01% 4628
2022
Q1 		$44K Sell
4,600
-24,500
-84% -$230K ﹤0.01% 6180
2021
Q4 		$336K Buy
29,100
+1,200
+4% +$13.4K ﹤0.01% 4557
2021
Q3 		$266K Sell
27,900
-32,600
-54% -$333K ﹤0.01% 4878
2021
Q2 		$583K Sell
60,500
-182,300
-75% -$1.78M ﹤0.01% 4047
2021
Q1 		$2.4M Buy
242,800
+214,300
+752% +$3.32M ﹤0.01% 2263
2020
Q4 		$658K Buy
28,500
+11,900
+72% +$243K ﹤0.01% 3038
2020
Q3 		$234K Sell
16,600
-6,400
-28% -$93.3K ﹤0.01% 3529
2020
Q2 		$347K Sell
23,000
-43,200
-65% -$526K ﹤0.01% 2920
2020
Q1 		$612K Sell
66,200
-26,000
-28% -$247K 0.01% 1904
2019
Q4 		$898K Buy
92,200
+10,400
+13% +$95.2K 0.01% 1969
2019
Q3 		$656K Sell
81,800
-17,800
-18% -$193K 0.01% 2107
2019
Q2 		$1.24M Buy
99,600
+85,900
+627% +$1.09M 0.01% 1450
2019
Q1 		$186K Buy
13,700
+6,700
+96% +$81.8K ﹤0.01% 2759
2018
Q4 		$67K Sell
7,000
-56,400
-89% -$620K ﹤0.01% 3400
2018
Q3 		$767K Sell
63,400
-41,800
-40% -$585K 0.01% 1915
2018
Q2 		$1.64M Sell
105,200
-121,300
-54% -$1.83M 0.01% 1284
2018
Q1 		$3.41M Sell
226,500
-434,300
-66% -$6.61M 0.03% 666
2017
Q4 		$9.51M Sell
660,800
-33,200
-5% -$456K 0.07% 357
2017
Q3 		$10.5M Buy
694,000
+507,900
+273% +$6.72M 0.1% 252
2017
Q2 		$1.87M Sell
186,100
-69,100
-27% -$556K 0.02% 993
2017
Q1 		$1.82M Sell
255,200
-395,800
-61% -$2.5M 0.02% 929
2016
Q4 		$3.23M Buy
651,000
+597,300
+1,112% +$4.13M 0.03% 635
2016
Q3 		$397K Buy
53,700
+10,500
+24% +$70.9K ﹤0.01% 1985
2016
Q2 		$236K Sell
43,200
-65,200
-60% -$456K ﹤0.01% 2286
2016
Q1 		$916K Sell
108,400
-288,600
-73% -$2.04M 0.01% 1239
2015
Q4 		$3.85M Buy
397,000
+15,800
+4% +$142K 0.05% 488
2015
Q3 		$5.33M Buy
381,200
+104,500
+38% +$1.64M 0.07% 333
2015
Q2 		$3.92M Buy
276,700
+35,400
+15% +$426K 0.05% 417
2015
Q1 		$2.63M Sell
241,300
-59,500
-20% -$524K 0.04% 510
2014
Q4 		$2.5M Buy
300,800
+34,100
+13% +$234K 0.04% 533
2014
Q3 		$1.59M Buy
266,700
+115,900
+77% +$607K 0.02% 826
2014
Q2 		$504K Buy
150,800
+144,200
+2,185% +$338K 0.01% 1637
2014
Q1 		$14K Sell
6,600
-200
-3% -$500 ﹤0.01% 4439
2013
Q4 		$16K Buy
6,800
+1,900
+39% +$4.17K ﹤0.01% 4368
2013
Q3 		$11K Sell
4,900
-80,400
-94% -$202K ﹤0.01% 4450
2013
Q2 		$199K Buy
+85,300
New +$262K ﹤0.01% 2173

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Group One Trading's FOLD Position: Q1 2026 in Review

Group One Trading reduced its Amicus Therapeutics (FOLD) stake by 42% in Q1 2026, selling an estimated $80.4K and leaving 7,861 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #4614.

Group One Trading first reported a position in FOLD in Q2 2013 and has held it in 37 quarters since. The position peaked at $4.24M in Q3 2017. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Group One Trading held 7,861 shares of Amicus Therapeutics worth $114K as of Q1 2026.
  • Group One Trading sold 5,608 Amicus Therapeutics shares in Q1 2026, an estimated $80.4K.
  • Amicus Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4614 holding.
  • Group One Trading first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 37 quarters since.
  • Group One Trading's Amicus Therapeutics position peaked at $4.24M in Q3 2017.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.